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Abstract
Background: A recent Dutch study in general practice showed a clear relationship between the
diagnosis of vulvovaginal candidiasis (VVC) and symptoms suggestive of provoked vulvodynia
(PVD). PVD accounts for the largest group of vulvar pains, but is often not recognised by GPs.
Aim: To investigate whether diagnostic uncertainty about VVC in general practice could also point
to the diagnosis of PVD, and whether and how this diagnostic uncertainty affects management.
Design & setting: An observational study in 2014 in Dutch general practices of the NIVEL Primary
Care Database.
Method: Women with an uncertain diagnosis of VVC were distinguished from those with certain
VVC based on the occurrence of recurrent episodes and persisting complaints, despite treatment.
Factors known to be associated with PVD were hypothesised to be more prevalent in women with
uncertain VVC. Data on symptom management by GPs were collected.
Results: In total 7066 women with VVC or uncertain VVC were included. Uncertain VVC was found
to account for 28% of these patients. Compared to VVC, the group uncertain VVC included
significantly more women with female genital symptoms, tiredness, irritable bowel syndrome (all
P<0.001), feeling anxious, reduced sexual desire, depressive disorder, relationship problems, and
micturition symptoms (all P<0.05). Compared to VVC, the group uncertain VVC included
significantly higher mean numbers of telephone consultations (P<0.001), more referrals to
gynaecology (P = 0.009), and higher mean numbers of prescriptions per patient (P<0.001).
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Conclusion: This study’s findings indicate that uncertain VVC could be a marker of PVD. GPs might
reconsider their diagnostics and management when women present recurrent and persistent
vulvovaginal complaints, especially if accompanied by dyspareunia, functional syndromes,
micturition symptoms, and psychological conditions.
How this fits in
Frequently, GPs are dealing with vulvovaginal complaints for which a diagnosis is not clear. Gener-
ally, mostly VVC is being considered. After excluding infections and dermatoses GPs might consider
the diagnosis of PVD when women present recurrent and persistent vulvovaginal complaints, espe-
cially if accompanied by dyspareunia, functional syndromes, micturition symptoms, and psychologi-
cal conditions.
Introduction
Vulvovaginal complaints are frequently presented in general practice. Approximately 25 per 1000
female patients per year visit their GP with VVC.1 Dutch GPs reported 106 consultations concerning
vaginal candidiasis per practice per year.2 About 25–30% of women with vulvovaginal complaints
remain without a microbiologically explained diagnosis, even after careful evaluation.3–6 One reason
may be that most GPs find it difficult to diagnose vulvovaginal complaints, perhaps leading to an
overestimation of VVC. A Dutch study showed that GPs do not perform the examinations required
to confirm their putative diagnosis, despite the recommendations given by the Dutch College of
GPs (DCGP’s) Guideline on Vaginal Discharge.1,2 Another reason for the apparently difficulty in diag-
nosing of VVC might be confusion with another diagnosis, for example, provoked vulvodynia (PVD).
PVD is the most common cause of vulvar pain, which is defined as ‘vulvar pain of at least 3
months duration, without clear identifiable cause, which may have potential associated factors.7 PVD
and VVC have partially cohering symptoms. Besides white crumbling discharge, criteria for VVC
involve vaginal itching and the appearance of redness of the vulva. Vaginal burning — often being
mistaken for itching — and redness of the vulva, although not obligatory, appear to be symptoms
of PVD as well. Both VVC and PVD can produce symptoms of irritation and tenderness in the vesti-
bule. Women often describe their discomfort in other phrases than ‘pain’, including itching, burning,
and a swelling sensation.8 Previous vaginal infections such as VVC and vaginosis have been identified
as important triggers and risk factors for PVD because of changes in the vaginal flora and immuno-
logical response, leading to neuropathic pain conditions of the vulva.8–12 Also, the strong relation-
ship between VVC and PVD may be explained by the possibility that women with VVC continue to
have intercourse despite the vulvovaginal pain they experience during and shortly after the infection,
possible leading to a vicious circle that maintains PVD.13 A recent retrospective cohort analysis in
Dutch general practices showed a clear relationship between VVC and symptoms suggestive of
PVD.14 It was hypothesised that the strong relation between VVC and PVD could be explained as
well by the possibility that VVC was misdiagnosed, actually covering a subgroup of women with
PVD. The prevalence of PVD in the general population is estimated to be between 3.1% and 15%,
mostly affecting women <50 years of age.15,16 The annual incidence in the general population is
estimated to be 3.1%.17
Since little is known about PVD in primary care and since PVD is not included in the International
Classification of Primary Care (ICPC), vulvovaginal symptoms suggestive of PVD may not be recog-
nised by the GP and consequently be registered as VVC. A lack of training in recognising PVD
among physicians could also play a role in this doctor’s delay.18,19 Another important factor is
patient delay: in a large prospective study in 300 patients it took an average of 38 months after
symptom-onset before women with PVD consulted a healthcare provider for the first time.20 PVD is
associated with several chronic pain conditions and mental health problems.14,21–24 Moreover, in
existing literature PVD is found to be associated with medically unexplained physical symptoms
(MUPS) as is seen in fibromyalgia, chronic fatigue, sleep disorders, and irritable bowel syn-
drome.20,21,25 A timely diagnosis of PVD may be helpful in improving the impaired quality of life of
patients and the consumption of extra medical care that is associated with PVD.26
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The aim of this study was to investigate whether diagnostic uncertainty about VVC is a marker of
PVD. The research questions were: do women with uncertain VVC differ from women with certain
VVC with respect to characteristics associated with PVD and, given the doctor’s delay, do GPs differ-
ently manage certain or uncertain VVC, and if so, how?
Method
A retrospective analysis of women with VVC and uncertain VVC in a representative primary care
database was performed. Differences between these groups in characteristics that according to the
literature were associated with PVD: female genital symptoms, psychological symptoms, MUPS, rela-
tionship problems with partner, and micturition symptoms were analysed.14,21–24
Data collection
Data were collected from NIVEL, a nationally representative primary care database, which uses rou-
tinely recorded data from GPs to monitor health and utilisation of health services in a representative
sample of the Dutch population. In this database GPs record all diagnoses and proceedings accord-
ing to the ICPC classification, during or immediately after the consultation. Diagnostic and manage-
ment data were used of women aged 10–50 years who were seen for vulvovaginal complaints by
their GP between 1 January 2014 and 1 January 2015. The following information was extracted from
the electronic medical record: relevant diagnoses and symptoms, additional tests, prescriptions,
type of contact, and referrals.
VVC and uncertain VVC
VVC and uncertain VVC were defined as follows.
VVC
According to the DCGP’s Guideline on Vaginal Discharge, a VVC (ICPC code X72) is considered very
likely, when the patient’s history and physical exam display itching and non-smelling, white crum-
bling discharge in combination with a red swollen vulva or vaginal wall.1 According to this Guideline
a physical exam can be omitted if the patient recognises the complaints from an earlier episode of
VVC. In case of doubt, a positive yeast culture or potassium hydroxide preparation showing hyphae
is indicated to establish a definite diagnosis.
Uncertain VVC, as is defined for the purposes of this study:
a. Recurrent VVC (RVVC): when a patient presents with three or more episodes of VVC within a
year, of which at least one is confirmed by the GP in a face-to-face consultation. The frequent
recurrence of a VVC might be an indication that in one way or another the GP’s management
was insufficient. To prevent missing patients with RVVC in 2014, patients were traced with
VVC once or twice in 2014, back to 2013.
b. Persisting VVC (PVVC): when a patient returns for a second consultation within one episode of
VVC, suggesting that the previous consultation was insufficient. Episodes, used in the NIVEL
Primary Care Database, are constructed periods for a specific diagnosis. Because a symptom-
free period for VVC lasts 8 weeks before a new episode of VVC can be started, a complaint
was considered persistent when a patient had consulted the GP at least two times with the
same complaint within a time period of 8 weeks.
Variables associated with PVD
Symptoms associated with PVD were selected based on the literature.14,25 These included female
genital symptoms (painful intercourse [X04], other symptoms/complaints vagina [X15], other symp-
toms/complaints vulva [X16], vaginitis/vulvitis not otherwise specified [NOS] [X84]), pain symptoms
(muscle pain [L18], irritable bowel syndrome [D93]), general weakness/tiredness (A04), psychological
conditions (feeling anxious/nervous/tense [P01], feeling depressed [P03], reduced sexual desire
[P07], depressive disorder [P76]), relationship problems (Z12), and micturition symptoms (dysuria/
painful urination [U01], urinary frequency/urgency [U02], urination problems other [U05], cystitis/
other infection [U71]) (Tables 1 and 2).
Leusink P et al. BJGP Open 2017; DOI: 10.3399/bjgpopen17X100905 3 of 8
Research
Analysis
Data from women diagnosed with VVC that were registered between 1 January 2014 and 1 January
2015 were analysed using the Statistical Product and Service Solutions (SPSS) (version 22). It was
investigated whether factors associated with PVD and whether medical activities were more
Table 1. Factors associated with provoked vulvodynia for vulvovaginal candidiasis (VVC) and uncertain VVC
VVC, % (n = 5088) Uncertain VVC, % (n = 1978) P-value
Female genital symptoms
Dyspareunia 1.1 2.1 <0.001a
Vaginal symptom/complaint other 6.9 10.3 <0.001a
Vulva symptom/complaint other 2.3 3.1 0.019 b
Vaginitis/vulvitis not otherwise specified 12.6 16.9 <0.001a
Medical unexplained symptoms
Weakness/tiredness in general 16.3 19.4 <0.001a
Muscle pain 4.2 4.8 0.186
Irritable bowel syndrome 5.3 6.9 0.001c
Psychological conditions
Feeling anxious/nervous/tense 5.3 6.3 0.047b
Feeling depressed 4.0 4.7 0.107
Sexual desire reduced 0.1 0.3 0.012b
Depressive disorder 5.1 6.7 0.002c
Relationship problem partner 3.5 4.4 0.029b
Micturition symptoms
Dysuria/painful urination 5.1 5.8 0.148
Urinary frequency/urgency 5.8 6.9 0.046b
Urination problems other 2.3 3.5 0.001c
Cystitis/other infection 27.3 29.6 0.015b
aP<0.001. bP <0.05. cP<0.01.
Table 2. Consultations, referrals, and prescriptions related to the disorder in patients with vulvovaginal candidiasis (VVC) and uncertain VVC
VVC (n = 5088) Uncertain VVC (n = 1978) P-value
Telephone consultation
Patients, n (%) 2898 (57.0) 1643 (83.1) <0.001a
Consultations per patient, mean (SD) 1.2 (1.7) 3.1 (4.1) <0.001a
Face-to-face consultation
Patients, n (%) 3524 (69.3) 1801 (91.1) <0.001a
Consultations per patient, mean (SD) 1.5 (2.0) 3.9 (4.6) <0.001a
Referrals
Patients referred to gynaecology, n (%) 222 (4.4) 351 (17.7) 0.009b
Patients referred for diagnostics, n (%) 156 (3.1) 241 (12.2) <0.001a
Patients with one or more referrals, n (%) 1246 (24.5) 995 (50.3) 0.006b
Prescriptions
Patients that received local treatment, n (%) 2956 (58.1) 1130 (57.1) 0.002b
Patients that received oral treatment, n (%) 579 (11.4) 442 (22.3) 0.673
Prescription per patient, mean (SD) 1.9 (1.5) 4.1 (3.2) <0.001a
aP<0.001. bP<0.01.
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prevalent in women with uncertain VVC relative to VVC. Statistical significance was computed using
the c2 test where P<0.05 was considered significant.
Results
Population
Of 379 190 women aged 10–50 years, representing data collected by 227 GPs, 7066 were diag-
nosed with VVC (1.8%). The mean age was 35.1 years (SD = 11.4).
Uncertain VVC
Of the patients that initially received the diagnosis VVC, 28% had uncertain VVC. Table 1 lists
comorbidities associated with PVD for VVC and uncertain VVC. Compared to certain VVC, patients
with uncertain VVC were diagnosed significantly more often with female genital symptoms
(P<0.001), especially dyspareunia, vaginal symptoms/complaints, and NOS vaginitis/vulvitis. Also,
patients with uncertain VVC showed a significantly higher incidence of general tiredness, irritable
bowel syndrome, reduced sexual desire, depressive disorder, relationship problems, and micturition
symptoms (Table 1).
Management by the GP
Mean number of consultations per patient with certain VVC was 4.3 (SD = 4.9). Patients that were
classified as having uncertain VVC had almost three times as many consultations; that is, 11.3
(SD = 11.9, P<0.001) (data not shown). For uncertain VVC the mean number per patient of tele-
phone consultations as well as face-to-face consultations, was significantly higher (Table 2). Patients
with uncertain VVC were four times as likely to be referred to a gynaecologist (P<0.001), and
received twice as many prescriptions per patient. Table 2 lists consultations, referrals, and prescrip-
tions in patients with VVC and uncertain VVC.
Discussion
Summary
Many factors known to be associated with PVD, especially dyspareunia, functional syndromes, mictu-
rition symptoms and psychological conditions, were found to be significantly more prevalent in
2014–2015 in the uncertain VVC group, such as women presenting recurrent and persistent vulvova-
ginal complaints. This reinforces the hypothesis that uncertain VVC could be a marker of PVD. Also,
the number of face-to-face and telephone consultation and the number of referrals, related to VVC
or uncertain VVC, were found to be significantly higher in the women with uncertain VVC. Because
uncertain VVC was found to account for a substantial part of 28% of all patients initially diagnosed
with VVC, this study’s findings may point, after excluding infections and dermatoses, to the exis-
tence of a subgroup of women with PVD within the group of women with uncertain VVC.
Strengths and limitations
A strength of this study is that the data included a large number of patients and their episodes, and
that the study was performed in a GP population representative of the general Dutch population.27
The GPs affiliated with NIVEL Primary Care Database are motivated to perform adequate ICPC
coding.
However, as no ICPC code for PVD is available, only indirect measures of PVD were available of
complaints or disorders known to be related to PVD. They lack specificity, however, as some of these
nonspecific complaints may also occur in case of lichen sclerosus or eczema, therefore possibly over-
estimating the hypothesised relation between uncertain VVC and PVD.
Using RVVC as a subtype of uncertain VVC might overestimate this relation as well because RVVC
can in fact be caused by a candida infection, especially in case of comorbidity such as diabetes melli-
tus, reduced immunity status, and use of immunity-decreasing drugs, for example antirheumatic and
chemotherapeutic drugs, corticosteroids, and antibiotics. Nevertheless, it should be emphasised
that one-third to one-half of RVVC cases have no clear cause.28
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On the other hand, the existence of a subgroup of PVD in the group VVC may also be underesti-
mated rather than overestimated. These data show a very low number of women with sexual com-
plaints, contrary to robust findings in the literature showing that in women with PVD reduced sexual
desire and response is common.25 This might indicate that GPs probably did not take a sexual his-
tory adequately.
In the past PVD was described as vulvar vestibulitis syndrome or focal vulvitis, both with the mis-
leading suffix of ’–itis’. It is possible that PVD was registered by GPs under the ICPC code vaginitis/
vulvitis (NOS), which in this study indeed was found to be significantly more prevalent in the group
of uncertain VVC. Since only general ICPC codes were accessible for research and subcodes were
not, this cannot be stated with certainty.
Comparison with existing literature
Women with uncertain VVC were twice more likely to have dyspareunia and three times more likely
to have reduced sexual desire, both found to be important characteristics of PVD.10,14,20,23,25
The current findings that women with uncertain VVC showed a significantly higher incidence of mic-
turition symptoms and of irritable bowel syndrome, are in line with findings related to chronic pelvic
pain as one of the maintaining factors in PVD.12,17,21,25 Also, psychological conditions and relation-
ship problems with a partner, known to be associated with PVD, are more prevalent in women with
uncertain VVC.24,29
Uncertain VVC was found to account for 28% of all patients diagnosed with VVC, which high num-
ber does correspond to the findings of a Dutch study on the factors associated with microbiologi-
cally unexplained vaginal symptoms, which showed that 25% of all the women had symptoms of
unknown aetiology.6 It shows the difficulty of diagnosing vulvovaginal complaints by GPs, as was
demonstrated previously among Dutch GPs.2 This difficulty has apparently repercussions for the
management of VVC by GPs as is seen in the significantly higher healthcare use in women with
uncertain VVC. While these findings may be the consequence of the definition of uncertain VVC
itself, it also could be an expression of the well-known association between MUPS and high health-
care use.30 Given the higher number of MUPS in the uncertain VVC group, and the difficulty in diag-
nosing PVD as a chronic pain disorder without clear identifiable cause, the higher number of
consultations and referrals may reflect the association between PVD and MUPS. A recent study
showed that GPs take various characteristics like multiple MUPS, frequent and long consultations
and many referrals into account when recognising MUPS in their patients.31 Equally, in case of uncer-
tain VVC, GPs should be aware that the increasing number of consultations and comorbidity of
MUPS could point to PVD.
It is unknown whether GPs ever consider PVD as an alternative diagnosis. Given the significantly
higher mean number of prescriptions received per patient in the women with uncertain VVC (twice
as many), GPs seem hold on to their initial diagnosis of VVC. This is in line with research that was
conducted among a group of Dutch GPs, some years after the introduction of the DCGP’s Guideline
on Vaginal Discharge, showing that GPs did not perform the examinations required to confirm their
putative diagnosis of VVC, leading to wrong diagnoses and maltreatment with antimycotics.2
This study’s results also demonstrate that despite requesting for diagnostics more often among
women with uncertain VVC, GPs referred more often to a gynaecologist as well. This is in line with a
study in patients with sexual complaints attending Dutch GPs, showing that women with a sexual
dysfunction were more often referred to secondary care services than were male patients with a sex-
ual dysfunction.32 If PVD were to be considered as a diagnosis, a referral to a pelvic floor physical
therapist or sexologist (or sexual and relationship therapist) rather than a gynaecologist would be
indicated, as is stated by the DCGP’s Guideline on Sexual Complaints.33 Other national guidelines
might be consulted to apply the referring policy correctly. Does the referral policy of the GPs in this
study suggest that they do not consider any alternative diagnosis when women’s vulvovaginal com-
plaints persist? This hypothesis would be consistent with studies that show that vulvodynia is under-
estimated and not recognised by GPs.30,34
Implications for research and practice
It is important for GPs to evaluate their diagnostics and management when persisting genital com-
plaints, dyspareunia, and PVD associated factors are present in a patient initially diagnosed as VVC.
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Rather than doing more of the same, in case of uncertainty about VVC, after excluding infections
and dermatoses, the GP might consider PVD, especially in situations of RVVC and PVVC.
Since an adequate diagnostic approach is needed for recognising PVD, more insight into the facil-
itating and limiting factors in the diagnostic process of GPs dealing with women with vulvovaginal
complaints, is recommended. Learning from the way GPs diagnose and manage MUPS could be
helpful.
Many factors known to be associated with PVD were found to be significantly more prevalent in
the uncertain VVC group. Diagnostic uncertainty about VVC could point to the diagnosis PVD. GPs
might reconsider their diagnostics and management when persistent and recurrent genital com-
plaints, dyspareunia, medical unexplained symptoms, micturition symptoms, and psychological con-
ditions are present in a patient initially diagnosed as VVC.
Funding
Expert Group on Sexual Health of the Dutch College of General Practitioners.
Ethical approval
The data collected by the NIVEL Primary Care Database from the GPs’ electronic medical record sys-
tem are ‘pseudonymised’, which implies that personal data are converted to a non-traceable code.
These conversions are irreversible, protecting the patient’s privacy. Given that the Medical Research
Involving Human Subjects Act of the Netherlands does not apply to data already present in the
NIVEL Primary Care Database, official approval of a Medical Ethics Committee was not required.
Provenance
Freely submitted; externally peer reviewed.
References
1. Dutch College of General Practitioners Working Group Vaginal discharge . Vaginal discharge. Guideline of
the Dutch College of General Practitioners, 2nd revision. Huisarts Wet 2016; 59: 204–210.
2. Engberts MK, Korporaal H, Vinkers M, et al. Vulvovaginal candidiasis: diagnostic and therapeutic approaches
used by Dutch general practitioners. Eur J Gen Pract 2008; 14(1): 30–33. doi: 10.1080/13814780701814929
3. Ventolini G. Vulvar pain: anatomic and recent pathophysiologic considerations. Clin Anat 2013; 26(1): 130–
133. doi: 10.1002/ca.22160
4. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA 2004; 291(11): 1368–1379. doi:
10.1001/jama.291.11.1368
5. Lowe NK, Neal JL, Ryan-Wenger NA. Accuracy of the clinical diagnosis of vaginitis compared with a DNA
probe laboratory standard. Obstet Gynecol 2009; 113(1): 89–95. doi: 10.1097/AOG.0b013e3181909f63
6. Dekker JH, Boeke AJ, Janssens J, et al. Vaginal symptoms of unknown aetiology: a study in Dutch general
practice. Br J Gen Pract 1993; 43(371): 239–244.
7. Bornstein J, Goldstein AT, Stockdale CK, et al. 2015 ISSVD, ISSWSH and IPPS consensus terminology and
classification of persistent vulvar pain and vulvodynia. Obstetrics & Gynecology 2016; 127(4): 745–751. doi:
10.1097/AOG.0000000000001359
8. De Andres J, Sanchis-Lopez N, Asensio-Samper JM, et al. Vulvodynia — an evidence-based literature review
and proposed treatment algorithm. Pain Pract 2016; 16(2): 204–236. doi: 10.1111/papr.12274
9. Bohm-Starke N. Medical and physical predictors of localized provoked vulvodynia. Acta Obstet Gynecol
Scand 2010; 89(12): 1504–1510. doi: 10.3109/00016349.2010.528368
10. Giraldo PC, Polpeta NC, Juliato CR, et al. Evaluation of sexual function in Brazilian women with recurrent
vulvovaginal candidiasis and localized provoked vulvodynia. J Sex Med 2012; 9(3): 805–811. doi: 10.1111/j.
1743-6109.2011.02584.x
11. Ventolini G. Vulvar pain: anatomic and recent pathophysiologic considerations. Clin Anat 2013; 26(1): 130–
133. doi: 10.1002/ca.22160
12. Nguyen RH, Swanson D, Harlow BL. Urogenital infections in relation to the occurrence of vulvodynia. J
Reprod Med 2009; 54(6): 385–392.
13. Brauer M, Lakeman M, van Lunsen R, et al. Predictors of task-persistent and fear-avoiding behaviors in
women with sexual pain disorders. J Sex Med 2014; 12: 3051.
14. Leusink P, Kaptheijn A, Laan E, et al. Comorbidities among women with vulvodynia in family practice. J Sex
Med 2016; 13: 220–225.
15. Harlow BL, Wise LA, Stewart EG. Prevalence and predictors of chronic lower genital tract discomfort. Am J
Obstet Gynecol 2001; 185(3): 545–550. doi: 10.1067/mob.2001.116748
16. Reed BD, Crawford S, Couper M, et al. Pain at the vulvar vestibule: a web-based survey. J Lower Genit Tract
Dis 2004; 8(1): 48–57. doi: 10.1097/00128360-200401000-00011
17. Reed BD, Payne CM, Harlow SD, et al. Urogenital symptoms and pain history as precursors of vulvodynia: a
longitudinal study. J Womens Health (Larchmt) 2012; 21(11): 1139–1143. doi: 10.1089/jwh.2012.3566
Leusink P et al. BJGP Open 2017; DOI: 10.3399/bjgpopen17X100905 7 of 8
Research
18. Toeima E, Nieto J. Junior doctors’ understanding of vulval pain/vulvodynia: a qualitative survey.
Arch Gynecol Obstet 2011; 283 Suppl 1(S1): 101–104. doi: 10.1007/s00404-010-1513-2
19. Rosen R, Kountz D, Post-Zwicker T, et al. Sexual communication skills in residency training: the Robert Wood
Johnson model. J Sex Med 2006; 3(1): 37–46. doi: 10.1111/j.1743-6109.2005.00135.x
20. Sadownik LA. Clinical profile of vulvodynia patients. A prospective study of 300 patients. J Reprod Med
2000; 45(8): 679–684.
21. Reed BD, Harlow SD, Sen A, et al. Relationship between vulvodynia and chronic comorbid pain conditions.
Obstet Gynecol 2012; 120(1): 145–151. doi: 10.1097/AOG.0b013e31825957cf
22. Westling AM, Tu FF, Griffith JW, et al. The association of dysmenorrhea with noncyclic pelvic pain
accounting for psychological factors. Am J Obstet Gynecol 2013; 209(5): 422.e1–422.e10. doi: 10.1016/j.
ajog.2013.08.020
23. Brauer M, ter Kuile MM, Janssen SA, et al. The effect of pain-related fear on sexual arousal in women with
superficial dyspareunia. Eur J Pain 2007; 11(7): 788–798. doi: 10.1016/j.ejpain.2006.12.006
24. Alappattu MJ, Bishop MD. Psychological factors in chronic pelvic pain in women: relevance and application
of the fear-avoidance model of pain. Phys Ther 2011; 91(10): 1542–1550. doi: 10.2522/ptj.20100368
25. Basson R. The recurrent pain and sexual sequelae of provoked vestibulodynia: a perpetuating cycle. J Sex
Med 2012; 9(8): 2077–2092. doi: 10.1111/j.1743-6109.2012.02803.x
26. Xie Y, Shi L, Xiong X, et al. Economic burden and quality of life of vulvodynia in the united states. Curr Med
Res Opin 2012; 28(4): 601–608. doi: 10.1185/03007995.2012.666963
27. NIVEL. NIVEL primary care database. https://www.nivel.nl/en/dossier/nivel-primary-care-database (accessed
28 Apr 2017).
28. Powell AM, Nyirjesy P. Recurrent vulvovaginitis. Best Pract Res Clin Obstet Gynaecol 2014; 28(7): 967–976.
doi: 10.1016/j.bpobgyn.2014.07.006
29. Rosen NO, Bergeron S, Sadikaj G, et al. Relationship satisfaction moderates the associations between male
partner responses and depression in women with vulvodynia: a dyadic daily experience study. Pain 2014;
155(7): 1374–1383. doi: 10.1016/j.pain.2014.04.017
30. den Boeft M, Twisk JW, Terluin B, et al. The association between medically unexplained physical symptoms
and health care use over two years and the influence of depressive and anxiety disorders and personality
traits: a longitudinal study. BMC Heal Serv Res 2016; 16: 100. doi: 10.1186/s12913-016-1332-7
31. den Boeft M, Huisman D, van der Wouden JC, et al. Recognition of patients with medically unexplained
physical symptoms by family physicians: results of a focus group study. BMC Fam Pract 2016; 17(1): 55. doi:
10.1186/s12875-016-0451-x
32. Kedde H, Donker G, Leusink P, et al. The incidence of sexual dysfunction in patients attending Dutch
general practitioners. Int J Sexual Health 2011; 23(4): 269–277. doi: 10.1080/19317611.2011.620686
33. Dutch College of General Practitioners Working Group Sexual Complaints . Sexual complaints. Guideline of
the Dutch College of General Practitioners. Huisarts Wet 2015; 58(11): 586–597.
34. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we
underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003; 58(2): 82–88.
Leusink P et al. BJGP Open 2017; DOI: 10.3399/bjgpopen17X100905 8 of 8
Research
